8-K
PETMED EXPRESS INC (PETS)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): July 18, 2022
| PetMed Express, Inc.<br> (Exact name of registrant as specified in its charter) | ||
|---|---|---|
| Florida | 000-28827 | 65-0680967 |
| --- | --- | --- |
| (State or other jurisdiction<br> of incorporation) | (Commission<br> File Number) | (I.R.S. Employer<br> Identification No.) |
| 420 South Congress Avenue Delray Beach, FL 33445 | ||
| --- | ||
| (Address of principal executive offices) (Zip Code) | ||
| (561) 526-4444 | ||
| --- | ||
| (Registrant’s telephone number, including area code) | ||
| Not Applicable | ||
| --- | ||
| (Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|---|---|
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
|---|---|---|
| Common Stock, par value $.001 per share | PETS | NASDAQ Global Select Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
1
Item 7.01. Regulation FD Disclosure.
On July 18, 2022, PetMed Express, Inc. issued a press release regarding the appointment of Christine Chambers as the Company’s CFO effective August 3, 2022. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.
The information in this Item 7.01 and the information contained in Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference in any Company filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof and regardless of any general incorporation language in such filings, except as shall be expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
| (d) | Exhibits. |
|---|---|
| 99.1 – Press release dated July 18, 2022.<br><br> <br>104 – Cover Page Interactive Data File (formatted as Inline XBRL). |
EXHIBIT INDEX
| Exhibit No. | Description |
|---|---|
| 99.1<br><br> <br>104 | Press release dated July 18, 2022.<br><br> <br>Cover Page Interactive Data File (formatted as Inline XBRL). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: July 18, 2022
| PETMED EXPRESS, INC. | |
|---|---|
| By: | /s/ Bruce S. Rosenbloom |
| Name: | Bruce S. Rosenbloom |
| Title: | Chief Financial Officer |
2
ex_396005.htm
Exhibit 99.1
July 18, 2022
PetMeds® Hires Christine Chambers as Chief Financial Officer
Seasoned executive brings a wealth of financial leadership to further accelerate the company’s digital transformation.
DELRAY BEACH, Fla. — PetMed Express, Inc. (NASDAQ: PETS), Your Trusted Pet Health Expert, announces the appointment of Christine Chambers as its Chief Financial Officer, effective on August 3, 2022.
Chambers is an experienced finance professional with extensive knowledge in the digital consumer space, most recently serving as Senior Vice President, CFO and Treasurer of Seattle-based RealNetworks. Prior to that, she was Vice President of Finance at Rosetta Stone. Chambers also has served as Deputy Director, Budget and Planning at the Bill & Melinda Gates Foundation. She earned an MBA from the University of Washington and a bachelor's degree in finance from Loughborough University, UK. She is an Associate Member of the Chartered Global Management Accountants (CGMA).
“We have made a lot of progress over the last several quarters to reinvigorate the iconic PetMeds business,” said Matt Hulett, President and CEO of PedMed Express. “We have invested in people, product, and strategy, including our foray into the pet telemedicine space. Our new leadership team has both digital transformation and scale experience, and the Board and I are thrilled to welcome Christine to the company. She is a seasoned finance professional with extensive experience in digital transformation in public and private companies. We have worked closely together for over 20 years, and I know first-hand that she has the turnaround chops and experience to help PetMeds into its next phase of growth.”
Chambers, who will report to Hulett, succeeds Bruce Rosenbloom, who will work with the company through a transitionary period for several months to ensure a smooth handoff. “The Board and I would like to thank Bruce for his myriad contributions to PetMeds through over 20 years of service to the company,” Hulett added.
“I am beyond happy and grateful for the opportunity to be working with Matt Hulett and the PetMeds team during this exciting period of growth and transformation,” Chambers said. “I look forward to adding to the company’s operational excellence in the realms of finance, budget, planning, governance, and more. And, of course, I am eager to help PetMeds provide the best products and services to millions of pet parents.”
ABOUT PETMEDS
Founded in 1996, PetMed Express is Your Trusted Pet Health Expert, delivering prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and through its website at petmeds.com.
FORWARD LOOKING STATEMENTS: The statements contained in this press release that are not purely historical are forward-looking statements, including statements regarding PetMeds’ expectations, beliefs, intentions or strategies regarding the future. All forward-looking statements included in this press release are based upon information available to PetMeds as of the date hereof, and PetMeds assumes no obligation to update any such forward-looking statements. Forward-looking statements involve risks and uncertainties, which could cause actual results to differ materially from those projected. These and other risks relating to PetMeds’ business are set forth in PetMeds’ Form 10-K for the fiscal year ended March 31, 2022, filed with the Securities and Exchange Commission.
MEDIA CONTACT
Mary Eva Tredway
Butin PR
maryeva@butinpr.com